# Feasibility Study to Assess a Trans-nasal Intestinal Potential Difference Probe

> **NCT04565821** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 15 (estimated)

## Conditions studied

- Inflammatory Disease
- Permeability; Increased
- Crohn Disease
- Inflammatory Bowel Diseases
- Environmental Enteropathy

## Interventions

- **DEVICE:** IPD Probe via TNIT

## Key facts

- **NCT ID:** NCT04565821
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-11-12
- **Primary completion:** 2027-04-30
- **Final completion:** 2028-04-30
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04565821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04565821, "Feasibility Study to Assess a Trans-nasal Intestinal Potential Difference Probe". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04565821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*